Christopher W Krueger
CIK 1394208 · CHIEF BUSINESS OFFICER · last filed 2024-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
44
Lifetime Open-Market Net
-$7.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | CHIEF BUSINESS OFFICER | 284,999 | $13.99 | $3.99M | -$6.76M | 22 | 2024-04-03 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | SVP & CBO | 3,933 | — | — | -$1.16M | 13 | 2010-07-26 |
Recent Filings · Page 3 of 5
44 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-03 | Ventyx Biosciences, Inc. (VTYX) Delisted | Notice (144) | −15,000 | -$566.1K | EDGAR |
| 2023-04-05 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | −6,553 | -$461.1K | EDGAR |
| 2023-01-18 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-23 | Ventyx Biosciences, Inc. (VTYX) Delisted | Sell (S) | −3,654 | -$115.5K | EDGAR |
| 2022-12-20 | Ventyx Biosciences, Inc. (VTYX) Delisted | Exer (M) | +10,480 | $0 | EDGAR |
| 2022-12-15 | Ventyx Biosciences, Inc. (VTYX) Delisted | Sell (S) | −30,000 | -$1.03M | EDGAR |
| 2022-12-06 | Ventyx Biosciences, Inc. (VTYX) Delisted | Sell (S) | −50,000 | -$1.45M | EDGAR |
| 2022-08-24 | Ventyx Biosciences, Inc. (VTYX) Delisted | Exer (M) | +169,361 | $33.9K | EDGAR |
| 2022-02-04 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-17 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.